These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2576924)

  • 21. Effect of prostaglandin E1 on vasoactive intestinal polypeptide release from the hypothalamus and on prolactin secretion from the pituitary in rats.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Ohta H; Yanaihara N; Imura H
    Endocrinology; 1983 Dec; 113(6):2059-64. PubMed ID: 6685619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
    Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
    Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution.
    Berelowitz M; Firestone SL; Frohman LA
    Endocrinology; 1981 Sep; 109(3):714-9. PubMed ID: 6114854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of opioid peptides and potassium on the release of vasoactive intestinal polypeptide and thyrotropin releasing hormone from perifused rat hypothalami.
    Burns G; Baker DJ; Brown BL; Dobson PR
    Life Sci; 1987 Mar; 40(10):951-7. PubMed ID: 3102870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical and diencephalic cells in dispersed cell culture.
    Tapia-Arancibia L; Reichlin S
    Brain Res; 1985 Jun; 336(1):67-72. PubMed ID: 2860951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immature rat ovary is innervated by vasoactive intestinal peptide (VIP)-containing fibers and responds to VIP with steroid secretion.
    Ahmed CE; Dees WL; Ojeda SR
    Endocrinology; 1986 Apr; 118(4):1682-9. PubMed ID: 3512260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vasoactive intestinal polypeptide on hypothalamic-pituitary-thyroid axis in rats.
    Mitsuma T; Nogimori T; Chaya M
    Endocrinol Exp; 1984 Jun; 18(2):93-100. PubMed ID: 6430673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system.
    Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and secretion of vasoactive intestinal peptide by rat fetal cerebral cortical and hypothalamic cells in culture.
    Lorenzo MJ; Sánchez-Franco F; de los Frailes MT; Reichlin S; Férnandez G; Cacicedo L
    Endocrinology; 1989 Oct; 125(4):1983-90. PubMed ID: 2507286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulatory effect of glucose on VIP-induced gastric somatostatin release.
    Schmid R; Schusdziarra V; Classen M
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E756-9. PubMed ID: 2897796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric somatostatin release: evidence for direct mediation by calcitonin gene-related peptide and vasoactive intestinal peptide.
    Zdon MJ; Adrian TE; Modlin IM
    J Surg Res; 1988 Jun; 44(6):680-6. PubMed ID: 2898038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PRF activity of VIP in vitro (author's transl)].
    Arancibia S; Enjalbert A; Ruberg M; Priam M; Bluet-Pajot MT; Kordon C
    J Physiol (Paris); 1981 Mar; 77(8):979-83. PubMed ID: 6122734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
    Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
    Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide.
    Watanobe H; Takebe K
    Neuropeptides; 1992 Oct; 23(2):115-9. PubMed ID: 1333573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
    Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
    Carter RF; Bitar KN; Zfass AM; Makhlouf GM
    Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
    Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
    Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.